Trial site
Coastal Carolina Research Center
North Charleston, South Carolina 29405, United StatesNot linked to an institution yet
- 13running trials
- 23closed trials
The trials here
What the 37 trials at this site are about, from their registry records.
- Phase
- Phase 321 trials
- Phase 210 trials
- Phase 1/22 trials
- Phase 2/32 trials
- Phase 42 trials
- Status
- Completed21 trials
- Active, not recruiting8 trials
- Recruiting5 trials
- Terminated2 trials
- Suspended1 trial
- Lead sponsor
- Pfizer4 trials
- Biohaven Therapeutics Ltd.3 trials
- TriGemX Bio, Inc.3 trials
- Cingulate Therapeutics2 trials
- Eli Lilly and Company2 trials
- and 20 more
Running trials
Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
NCT07674654· Phase 3· TriGemX Bio, Inc.· Source
Contact: Annemarie Vance
Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
NCT07645924· Phase 3· TriGemX Bio, Inc.· Source
Contact: Annemarie Vance
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
NCT07351058· Phase 3· Hoffmann-La Roche· Source
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
NCT07231419· Phase 3· Vertex Pharmaceuticals Incorporated· Source
Active, not recruiting
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
NCT06741228· Phase 3· Definium Therapeutics US, Inc.· Source
Active, not recruiting
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
NCT06565611· Phase 2· Palatin Technologies, Inc· Source
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
NCT04781140· Phase 4· Supernus Pharmaceuticals, Inc.· Source
Contact: Olivia Elbaum
Active, not recruiting
Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis
NCT06121882· Phase 3· Lipogems International spa· Source
Active, not recruiting
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
NCT06098079· Phase 4· Currax Pharmaceuticals· Source
Active, not recruiting
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
NCT05968430· Phase 3· Mineralys Therapeutics Inc.· Source
Active, not recruiting
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
NCT05164094· Phase 1/2· ModernaTX, Inc.· Source
Active, not recruiting
RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee
NCT05318521· Phase 3· Overseas Pharmaceuticals, Ltd.· Source
Active, not recruiting
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain
NCT04809376· Phase 2/3· Paradigm Biopharmaceuticals USA (INC)· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
NCT07365826· Phase 3· Vaxcyte, Inc.· Source
Completed
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
NCT06848075· Phase 2· TriGemX Bio, Inc.· Source
Completed
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
NCT06821061· Phase 1/2· BioNTech SE· Source
Completed
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
NCT06785012· Phase 2· Janssen Research & Development, LLC· Source
Completed
Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine
NCT06603623· Phase 2· Biohaven Therapeutics Ltd.· Source
Completed
Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)
NCT06423781· Phase 2· Biohaven Therapeutics Ltd.· Source
Completed
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers
NCT06435221· Phase 3· Achieve Life Sciences· Source
Completed
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
NCT06419608· Phase 2· Biohaven Therapeutics Ltd.· Source
Completed
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
NCT06254612· Phase 2· Sirtsei Pharmaceuticals, Inc.· Source
Completed
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
NCT06077864· Phase 3· Boehringer Ingelheim· Source
Completed
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
NCT05286762· Phase 3· Cingulate Therapeutics· Source
Completed
A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).
NCT05886777· Phase 2· Pfizer· Source
Completed
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
NCT05769608· Phase 2· Mineralys Therapeutics Inc.· Source
Completed
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
NCT05634811· Phase 3· Pfizer· Source
Completed
Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee
NCT05449132· Phase 3· Grünenthal GmbH· Source
Completed
Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee
NCT05377489· Phase 3· Grünenthal GmbH· Source
Completed
A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older
NCT05540522· Phase 3· Pfizer· Source
Completed
A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.
NCT05279313· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source
Terminated
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
NCT05085366· Phase 3· ModernaTX, Inc.· Source
Terminated
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
NCT04804033· Phase 2/3· Pfizer· Source
Completed
Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
NCT04636229· Phase 3· Organogenesis· Source
Recruiting
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
NCT05986292· Phase 2· Eli Lilly and Company· Source
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
NCT04184622· Phase 3· Eli Lilly and Company· Source
Report an error